Vol. 11, Issue 9, Part E (2025)

Abstract
Probiotics, defined by the FAO/WHO as "live microorganisms that, when administered in adequate amounts, confer a health benefit on the host," represent a burgeoning sector of the global functional food market. Their purported benefits, spanning improved gut health, enhanced immunity, and reduced risk of various non-communicable diseases, have fueled intense consumer interest and industrial innovation. However, the successful integration of these delicate microbial cultures into food matrices faces significant technological and biological obstacles. The primary challenge is maintaining the requisite viability—typically ≥106 to ≥107 Colony Forming Units (CFU) per gram or milliliter—throughout food processing, storage, and passage through the harsh environment of the gastrointestinal (GI) tract. Factors such as low pH, high oxygen concentration, processing temperatures, and interactions within the food matrix drastically compromise probiotic survival. Furthermore, ensuring the safety of novel strains, particularly concerning the transfer of antibiotic resistance genes and potential for systemic infection in immunocompromised individuals, remains a critical regulatory and scientific concern. To overcome these hurdles, cutting-edge solutions are emerging. Next-generation probiotics (NGPs), encompassing strict anaerobes like Akkermansia and Faecalibacterium, offer new therapeutic potential but demand highly specialized delivery systems. The most promising technological innovation is microencapsulation, utilizing materials like alginate, chitosan, and various hydrogels, which provides a protective barrier against environmental stresses and targeted release in the colon. Other strategies include the development of synbiotics (probiotics combined with prebiotics), the selection of robust, stress-tolerant strains, and the exploration of novel food carriers beyond traditional dairy, such as non-dairy beverages and fermented cereals. This paper reviews the multifaceted challenges in incorporating viable and effective probiotics into food products and details the current and future innovative strategies aimed at enhancing their viability, efficacy, and safety, thereby unlocking their full therapeutic potential in the functional food industry.